-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN CA89620X5064
ISIN CA89620X5064
WKN A12FG3
Symbol TRIL
Währung
USD
Marktkapitalisierung
691.000.000
Mitarbeiter
33
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 6,69 EUR -1,53%
ETFs die in Trillium Therapeutics Inc investieren
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
69 News & Informationen zur Trillium Therapeutics Inc Aktie
Pfizer to pay $2.26 billion for cancer treatment developer Trillium
Cancer treatments brought in $10.9 billion in revenue last year, and Pfizer’s oncology products include treatments for breast, colorectal, blood and lung cancers.
Pfizer And Moderna Rally After FDA Grants Full Approval To Pfizer's Covid-19 Vaccine
Pfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.
Wall Street rebounds as banks, energy surge
Wall Street’s main indexes rose on Monday, with banks and energy shares leading the gains, as investors returned to riskier assets after a sharp selloff last…
Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B
Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.
Pfizer to pay $2.26B for cancer treatment developer Trillium
Pfizer is spending more than $2 billion in cash to buy another drugmaker focused on potential cancer treatments
Stocks rally as investors eye Fed's Jackson Hole event
Stocks rallied as investors eyed a key Federal Reserve event that could lay the framework to begin the central bank's tapering process.
+++Börsen-Ticker+++ – Weitere Erholung an der Wall Street – Bei Bitcoin rückt das Rekordhoch wieder in den Fokus – Ölpreise erholen sich deutlich von Dreimonatstief
An den US-Börsen zeichnet sich erst einmal eine Fortsetzung der am Freitag begonnenen Erholung ab.
Pfizer to acquire cancer drugmaker Trillium Therapeutics for $2.3 bn
Read more about Pfizer to acquire cancer drugmaker Trillium Therapeutics for $2.3 bn on Business Standard. Pfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement.
Trillium Therapeutics : VOTING SUPPORT AGREEMENT (Form 8-K)
VOTING SUPPORT AGREEMENT
THIS AGREEMENT is made as of the 20th day of August, 2021.
BETWEEN:
PF ARGENTUM ACQUISITION ULC, a corporation formed… | August 23, 2021
Stock futures rally as investors eye Fed's Jackson Hole event
Stock futures rallied as investors eyed a key Federal Reserve event that could lay the framework to begin the central bank's tapering process.
Futures Rise As Jackson Hole Looms, Dollar Slides, Bitcoin Surges
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Acuta Capital Partners, Llc Buys BCLS Acquisition Corp, Vincerx Pharma Inc, Cyteir Therapeutics Inc, Sells 89bio Inc, Curis Inc, Trillium Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
TSX Extends Losing Streak To 5th Session
(RTTNews) – The Canadian market, which recovered after weak start, moved along the flat line for much of the day's session on Wednesday, and event…
Canadian Market Roughly Flat In Cautious Trade; Healthcare Stocks Move Up
(RTTNews) – The Canadian market is flat Wednesday afternoon with stocks turning in a mixed performance as investors largely stay cautious and make…
Trillium Therapeutics Inc. Stock Quote (U.S.: Nasdaq)
TRIL | Complete Trillium Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Fairmount Funds Management LLC Buys Instil Bio Inc, Zogenix Inc, Insmed Inc, Sells Mirati Therapeutics Inc, Seres Therapeutics Inc, Trillium Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Canadian Market Modestly Higher In Cautious Trade
(RTTNews) – The Canadian stock market is modestly higher a little past noon on Friday, thanks to strong gains in materials section. Shares from …
EDGAR Filing Documents for 0001558370-21-011562
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing…
TSX Ends Weak
(RTTNews) – The Canadian stock market ended weak on Thursday after languishing in negative territory right through the day's session as investors …
Canadian Market Remains Weak As Energy, Materials Shares Drift Lower
(RTTNews) – The Canadian stock market remains weak Thursday afternoon with investors largely making cautious moves, reacting to earnings updates a…
This Biotech Stock Is Too Cheap to Ignore
Wall Street's short attention span has created an attractive entry point in this once-loved biotech.
TSX falls 0.12% to 20,164.96
* The Toronto Stock Exchange's TSX falls 0.12 percent to 20,164.96
* Leading the index were Lithium Americas Corp , up 6.7%, Stelco Holdings Inc, up 6.4%, and Equinox… | July 26, 2021
Here is What Hedge Funds Think About Diebold Nixdorf Incorporated (DBD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Canadian Market Ends Notably Lower
(RTTNews) – The Canadian market ended with pronounced losses on Friday as stocks from materials, energy and healthcare sections tumbled on selling…
Canadian Recovers After Weak Start, Up Marginally An Hour Past Noon
(RTTNews) – The Canadian stock market is modestly higher Thursday afternoon, aided by gains in consumer staples, industrials and materials shares….
TSX Ends Notably Lower
(RTTNews) – The Canadian stock market ended notably lower on Wednesday, dragged down by loss in healthcare, energy and information technology shar…
CANADA STOCKS – TSX rises 0.98% to 20,257.95
* The Toronto Stock Exchange's TSX rises 0.98 percent to 20,257.95
* Leading the index were Sunopta Inc , up 7.8%, Methanex Corp, up 5.8%, and Lithium Americas… | July 9, 2021
Canadian Market Down In Negative Territory As Energy Stocks Tumble
(RTTNews) – The Canadian stock market is down in negative territory, having slumped after a slightly positive start Tuesday morning. Firm bullio…
Trillium Therapeutics Appoints Catherine Mackey, Ph.D., To Its Board Of Directors
CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage
Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-621 in Combination With Doxorubicin in Leiomyosarcoma
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing…
Is Brooge Energy Limited (BROG) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,…
Trillium Therapeutics Joins Russell 2000® and 3000® Indices
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage…
TSX Ends Lower On Weak Retail Sales Data
(RTTNews) – The Canadian stock market ended on a weak note on Wednesday after struggling for direction right through the session, as weak retail s…
Trillium Therapeutics' CD47 Lead Evokes Pfizer's Interest (NASDAQ:TRIL)
Trillium Therapeutics is a leader in the CD47 inhibitor space in terms of data claims, and Pfizer has recently taken an interest.
TSX Ends Marginally Higher
(RTTNews) – The Canadian stock market ended on a positive note on Thursday after staying firm right through the session. Strong gains in healthcar…
3 Top Biotech Picks for January
Buy these three biotech stocks before they take off.
1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021
When it comes to countering a key trick that cancer plays on the human immune system, this biotech has no equal.
Canadian Stocks Firmly Up In Positive Territory
(RTTNews) – The Canadian stock market was firmly entrenched in positive territory a little past noon on Wednesday, thanks to strong gains recorded…